4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-064253
Chief Financial Officer sold 10,000 shares at an average $34.98 ($349,800)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…